Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nurminen Logistics Plc’s financial information schedule for 2024

Nurminen Logistics Plc      Stock Exchange Release December 18, 2023, at 10.00 am In 2024, Nurminen Logistics Oyj will publish financial reports as follows: The Financial Statement Bulletin for 2023 on Thursday, 29[th] of February 2024, at 9.00 am.Annual Report 2023, which includes the company’s financial statements, the report of the Board of Directors, the Remuneration Report, and the Corporate Governance Statement on Thursday, 14[th] of March 2024, at 9.00 am. Q1 Interim report for January-March on Thursday 25[th], April 2024, at 2.00 pm Half-year Report for January – June

“Microgravity: How Earth can benefit from Space” – A riveting documentary now streaming on Amazon Prime

What happens during a suborbital rocket campaign? This captivating documentary takes the viewer on an extraordinary journey to Esrange Space Center in northern Sweden, where researchers and scientists from all over the world had one common goal: Microgravity. Under the management of SSC, the SubOrbital Express-3 rocket was launched on 23 November 2022. Join an exploration of how space technology intersects with daily modern life on Earth. SSC brought together 12 diverse experiments onboard the SubOrbital Express-3 rocket, each using space conditions as a valuable tool for conducting

Disclosure of large shareholding

Reference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") regarding the allocation of shares in the rights issue of 137,193,548 new shares in the Company (the "Offer Shares"), at a subscription price of NOK 0.26 per share (the "Rights Issue"). Subject to the completion of the Rights Issue, resulting in the total number of issued shares in the Company being 190,685,204, Navamedic ASA will hold 4,222,727 shares in the Company, representing 2.21% of the share capital and votes in the Company, and consequently be below the disclosure threshold of

Disclosure of large shareholding

Reference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") regarding the allocation of shares in the rights issue of 137,193,548 new shares in the Company (the "Offer Shares"), at a subscription price of NOK 0.26 per share (the "Rights Issue"). In connection with the Rights Issue, ELI AS has been allocated 9,269,038 Offer Shares. Subject to the completion of the Rights Issue, resulting in the total number of issued shares in the Company being 190,685,204, ELI AS will hold 11,013,298 shares in the Company, representing 5.78% of the share capital

Repurchase of Truecaller B shares in week 50, 2023

During 11 December 2023 and 15 December 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 290,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until

Buybacks of shares in ITAB during week 50 2023

During the period between 11 and 15 December 2023, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 46,709 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse Regulation (“MAR”

Biosensors to characterize immune response to bacterial diseases

Within the research project “Advanced Materials for Personalized Medicine and Diagnostics  (AMPMeD)” at the Linnaeus University, the sub-projects, “Enhanced bacterial infection diagnosis” lead by Dr. Sofia Somajo is now initiating test of Borrelia infected individuals. Sera and dry blood samples will be tested according to Attanas immunity profiles concept.The AmPMeD project started previously this year and includes the entire chain from sampling, via analysis to reporting. The

Change in accounting practice for development costs related to Nordea’s digital services

Nordea has decided to change its accounting practice for development costs related to its digital services, following a review during the fourth quarter. Nordea’s current practice is to capitalise development costs and amortise them over their useful economic lives. Going forward, Nordea intends to expense such development costs as incurred. As a result of this change of accounting practice, in its fourth quarter results Nordea will record a EUR 130m write-off related to earlier capitalised development. Nordea is in a very strong position in digital development. Nordea’s digital customer

Valmet and Saipem signed a Memorandum of Understanding to develop integrated solutions to support decarbonization of hard-to-abate industries

Valmet Oyj’s press release on December 18, 2023 at 9:30 a.m. EETValmet and Saipem have signed a Memorandum of Understanding (MOU) to develop joint solutions to decarbonize the industrial sectors that face significant challenges in reducing their greenhouse gas emissions, also known as hard-to-abate industries. The companies will collaborate to offer effective solutions combining Saipem’s technologies for CO\2\ management with the heat recovery and flue gas treatment units engineered and produced by Valmet for the pulp, paper and energy segments, thus bringing integrated and flexible

Biokraft informs about Aneo Renewables Holding AS and St1 Sverige AB's intention to consolidate their shareholdings in Biokraft

Aneo Renewables Holding AS and St1 Sverige AB have today announced their intention to consolidate their ownership in Biokraft International AB (publ) ("Biokraft") into a jointly owned limited company, 1Vision Biogas AB ("1Vision Biogas"). The consolidation is subject to approval from relevant competition authorities and foreign direct investment (FDI) authorities and will not be completed until approvals have been obtained.  If such approvals are obtained, 1Vision Biogas' holding will amount to approximately 55 percent of the shares and votes in Biokraft, thereby exceeding the threshold

BioStock: Stayble’s new analyses of phase IIb study strengthen disc herniation project

Earlier this autumn, Stayble Therapeutics announced that the drug candidate STA363 had not met the primary endpoint in the phase IIb study in patients with degenerative disc disease. Now, however, additional analyses from the study are presented that may prove to have a bearing on the company’s other project regarding herniated discs. BioStock reached out to CEO Andreas Gerward to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2023/12/staybles-new-analyses-of-phase-iib-study-strengthen-disc-herniation-project/ This is a

Aneo, HitecVision and St1 join forces with the intention to consolidate ownership in Biokraft International, which would trigger a mandatory bid obligation

Aneo Renewables Holding AS[1] (“Aneo”) and St1 Sverige AB[2], that own approximately 36.5 per cent and 18.6 per cent, respectively, of the total number of shares and votes in Biokraft International AB (“Biokraft” or the “Company”), listed on Nasdaq First North Premier Growth Market, today announce their intention to consolidate their respective ownership in Biokraft into a newly established company, 1Vision Biogas AB[[[3]]] (“1Vision Biogas”) (the “Consolidation”). 1Vision Biogas will be owned 50 per cent by St1 Nordic Oy (“St1”) and 50 per cent by Daytona Holdco AS, a joint holding company

First day of trading in warrants of series 2023/2024 TO2

In December 2023, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) ("Cell Impact" or the "Company") carried out a rights issue of Units (the “Rights Issue”). The first day of trading in warrants of series 2023/2024 TO2 (the "Warrants") issued as part of the Rights Issue on Nasdaq First North Growth Market is tomorrow, 19 December 2023. The last day of trading in the Warrants is 25 September 2024. The Warrants will be traded under the short name (ticker) CI TO2.Through the Rights Issue, 128,905,776 Warrants have been issued. Each Warrant entitles the holder to subscribe for

Outokumpu invests in a pelletizing plant for biocoke in Tornio, Finland to accelerate the reduction of direct emissions

Outokumpu OyjPress releaseDecember 18, 2023 at 9.15 am EETOutokumpu invests in a pelletizing plant for biocoke in Tornio, Finland to accelerate the reduction of direct emissions Outokumpu is the global leader in sustainable stainless steel and is continuously looking for ways to further lower its climate impact across the value chain. Replacing fossil coke with renewable raw materials from biomass is one of the key drivers to reduce our direct emissions in our operations. As part of Outokumpu’s strategy to strengthen its leadership in sustainability and secure access to high-quality

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS18 December 2023 at 09:15NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive OfficerIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 46303/5/6 ____________________________________________Transaction date: 2023-12-12

CapMan Infra’s data centre platform appoints Maria Sundvall as Chief Executive Officer

CapMan Infra press release18.12.2023 at 09:00 AM EET CapMan Infra’s data centre platform appoints Maria Sundvall as Chief Executive Officer CapMan Infra’s data centre platform appoints Maria Sundvall, former EMEA Managing Director at digital infrastructure company Equinix, as its CEO. Maria joins the company with a strong entrepreneurial drive and extensive experience from the data centre sector, making her an ideal profile to lead the company to grow into a leading northern European data centre platform providing European-wide connectivity. Maria Sundvall (MSc Engineering) is an

Alvheim production restored after unplanned downtime

During the fourth quarter, Aker BP has experienced unplanned downtime at the Alvheim field due to technical issues. This has been resolved, and production is now restored. The downtime resulted from a malfunction in new equipment installed during maintenance activities in the previous quarter, causing a deferral of approximately one month in the production from the Alvheim area.  During restart of operations after the shutdown, approximately 50 cubic metres of oil leaked to the sea. The authorities were notified, proper oil spill response measures were successfully implemented, and no

Cloudberry Clean Energy ASA | Transactions made under the share buy-back programme

Oslo, 18 December. On October 31 Cloudberry Clean Energy ASA (“Cloudberry”) announced its decision to initiate a share buy-back programme.· The duration of the buy-back programme:  31 October 2023 until 31 December 2023 at the latest. · Size of the buy-back programme: Up to 3,000,000 shares, with a maximum total consideration of NOK 43,800,000. · During week 50 2023, Cloudberry purchased  316,470 own shares at an average price of NOK 10.1095 per share. Below is an overview of the transactions carried out under the buy-back programme. Date                                      |

Invitation to EQT’s Capital Markets Day

A warm welcome to EQT’s Capital Markets Day in Stockholm on Wednesday, 6 March 2024Since its inception nearly 30 years ago, EQT has grown to become a global leader in active ownership strategies. At its Capital Market Day, EQT will reflect on the journey to date, look ahead to the future of private markets, and how EQT is continuously evolving its thematic investment strategy and distinctive value creation approach to create superior returns for its clients. The event will be hosted by EQT’s CEO Christian Sinding, EQT’s Executive Committee, representatives from EQT’s Partner group, and

Acquisition of Precious Link (UK) Limited

18 December 2023                                                                                                                Everest Global plc (“Everest” or the “Company”) Acquisition of Precious Link (UK) Limited, a UK wine retailer Following the announcement on 4 July 2023, whereby the Company entered into an agreement to provide a loan of £200,000 to Precious Link (UK) Limited (“Precious Link”), Everest is today pleased to announce that it has entered into a share purchase agreement (“SPA”) with PI Distribution Investment Ltd, to acquire the entire issued share capital of

Nordec signed an implementation phase agreement with SRV for the Laakso Joint Hospital project

Nordec Group Oyj press release 18.12.2023 at 09.00 EET UTC+3 Nordec signed an implementation phase agreement with SRV on the delivery of the steel frame and frame installation of the northern part of the main building, including casting works for the Laakso Joint Hospital project The Laakso hospital area will be renewed in the 2020s. Two new hospital buildings will be built in the valley and two protected hospital buildings will be renovated. Laakso Hospital will provide psychiatric medical care, operations at Helsinki Hospital and, among other things, demanding neurological

Implantica adds another RefluxStop™ center in Spain

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.Dr. Pablo Priego performed his first two RefluxStop™ procedures at Universitario Ramón y Cajal Hospital in Madrid, Spain. The RefluxStop™ procedure aims to address the root cause of acid reflux or GERD without affecting the food passageway, allowing the body to function normally. "I appreciate the innovative approach that RefluxStop™ brings to the surgical treatment of GERD,

David von Laskowski once again a finalist for Large-Cap CEO of the Year

For the third consecutive year, David von Laskowski, CEO of Picadeli and the Greenfood Group, is a finalist for the CEO of the Year award in the large-cap company category. Under David's leadership, Greenfood Group has witnessed substantial profitable growth, continuing to expand its footprint beyond the Nordic domestic markets, across Europe and the US. This international growth has been propelled by Greenfood's subsidiary Picadeli, which now is Europe's leading fast-food company in the healthy food space.The CEO of the Year award, which was institutionalized more than a decade ago, is

There are no items matching the current filter
There are no more items matching the current filter
Back to top